anxiety | CARLAT PUBLISHING

CLINICAL UPDATE

Trichotillomania: Diagnosis and Treatment

October 30, 2022

Michael Posternak, MD.

Michael Posternak, MD. Psychiatrist in private practice, Boston, MA.

Dr. Posternak has no financial relationships with companies related to this material.

Trichotillomania (TTM) is a disorder that seems to lurk in the shadows. We hear about it but rarely see it.

Interpreting Assessment Discrepancies from Multiple Sources

October 17, 2022

Joshua Feder, MD and Mara Goverman

In this episode, we will discuss why assessment discrepancies arise, how we can manage them, and what these discrepancies tell us about a patient’s symptoms and response to treatment.

Throwback Thursday: Ginger Ale and Normal Hallucinations

October 13, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Is it ever normal to hear voices and is ginger ale really the best treatment for nausea?

Ask the Editor: Is Silexan Safe for Children and Adolescents?

October 1, 2022

Joshua Feder, MD

I’ve heard that Silexan/CalmAid lavender oil has been recommended for adults as a natural anxiolytic. Is it safe for kids?

Can CBD Work for PTSD?

September 25, 2022

Sin Yan Lo, PMHNP-BC

Sin Yan Lo, PMHNP-BC.

Ms. Lo, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Cannabidiol (CBD oil) is a popular self-remedy for anxiety and insomnia. A new study tests the drug in PTSD.

SAINT TMS Cleared for Treatment-Resistant Depression

September 12, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

On 9/6/22 the FDA approved Stanford’s SAINT Neuromodulation, an accelerated version of TMS that has raised hopes with unusually high remission rates.

Benzodiazepines: A Reevaluation of Their Benefits and Dangers

August 23, 2022

Carl Salzman MD

Carl Salzman, MD

Professor of Psychiatry at Harvard Medical School and past chairman of the American Psychiatric Association Benzodiazepine Task Force.

Interview by Marcia L. Zuckerman, MD. Board member of The Carlat Psychiatry Report; outpatient psychiatrist, Hallmark Health, Medford, MA; clinical assistant professor in psychiatry, Tufts School of Medicine. Edited by Chris Aiken, MD. Editor-in-Chief of TCPR; practicing psychiatrist, Winston-Salem, NC.

Drs. Salzman, Zuckerman, and Aiken have disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Former Chairman of the American Psychiatric Association Benzodiazepine Task Force Carl Salzman explains the legitimate medical use of benzodiazepines and their relevance in psychiatric practice.

What Works for Treatment Resistant Anxiety?

August 22, 2022

Chris Aiken, MD and Kellie Newsome, PMHNP

Silexan, an extract from Lavender with pharmaceutical properties, is one of only two treatments with a large effect size in generalized anxiety disorder. We rank all the treatments by strength and look to see if any of them can work when the SSRIs do not.